🇰🇷 TRILACICLIB in South Korea

TRILACICLIB (TRILACICLIB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

TRILACICLIB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRILACICLIB approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for TRILACICLIB in South Korea?

Marketing authorisation holder not available in our data.